Anti-Actin IgA Antibodies Identify Celiac Disease Patients with a Marsh 3 Intestinal Damage among Subjects with Moderate Anti-TG2 Levels
A new diagnostic tool (algorithm-1) for coeliac disease (CD) permitting the diagnosis without performing the duodenal biopsy has been recently proposed by the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). It combines symptoms associated with CD, high anti-tra...
Main Authors: | Enrico Schirru, Fabrice Danjou, Lucia Cicotto, Rossano Rossino, Maria Doloretta Macis, Rosanna Lampis, Rita-Désirée Jores, Mauro Congia |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2013/630463 |
Similar Items
-
Reliability of the Multiplex CytoBead CeliAK Immunoassay to Assess Anti-tTG IgA for Celiac Disease Screening
by: Diyora Abdukhakimova, et al.
Published: (2021-09-01) -
IgA anti-Actin antibodies in children with celiac disease: comparison of immunofluorescence with Elisa assay in predicting severe intestinal damage
by: Mora Stefano, et al.
Published: (2010-03-01) -
Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease
by: Stefania Martucciello, et al.
Published: (2020-05-01) -
Diagnostic accuracy of IgA anti-tissue transglutaminase antibody testing in celiac disease
by: Eremić Nevena, et al.
Published: (2012-01-01) -
Beyond the intestinal celiac mucosa: diagnostic role of anti TG2 deposits, a systematic review
by: Simona eGatti, et al.
Published: (2014-05-01)